SANTA CLARA, Calif.—Crown Bioscience, a wholly owned subsidiary of Crown Bioscience International, is expanding its management team with the appointment of Laurie Heilmann as chief business officer. Heilmann is a current member of the company, having served as senior vice president of global strategy, business development and marketing since 2014. In her new role, Heilmann will handle the company’s worldwide sales, strategy and marketing.

 

“I am honored to be assuming the role of chief business officer at Crown Bioscience,” Heilmann said in a news release. “I look forward to continuing to work with Dr. Wery and our talented, dedicated team of scientists, business development and marketing professionals building our translational technology platform to help our clients address global health challenges.”